Eli Lilly News

Eli Lilly is a pharmaceutical company that recently acquired Merida Biosciences to expand its immunology business.

Eli Lilly Buys Merida Biosciences for Up to $2.88B

1mo

Mounjaro Approved to Reduce Heart Event Risk in Type 2 Diabetes Patients

Mounjaro approved to cut heart risks in type 2 diabetes

UK Approves New Weight Loss Pill, First in Europe

Novo Nordisk sues Eli Lilly over obesity drug ads

Novo Nordisk has filed a lawsuit against rival Eli Lilly in the U.S., alleging misleading advertising for its obesity treatments, including Zepbound and Mounjaro. The legal action occurs amid intense competition in the multi-billion dollar weight-loss drug market.

2mo

Eli Lilly is a pharmaceutical company that recently acquired Merida Biosciences to expand its immunology business.